Letrozole for preparing the womb before embryo transfer
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This study tests if a medicine called letrozole can help prepare the lining of the womb for a frozen embryo transfer. It may be an option for women under 40 who have had limited previous IVF cycles.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are under 40 years old.
- You are going through IVF or ICSI and have had no more than 3 treatment cycles.
- You have at least 2 early-stage or 1 later-stage frozen embryo stored.
- You have had no more than 2 previous embryo transfers.
- You do not have certain conditions like uterine problems, severe endometriosis, or genetic testing needs.
- Your BMI is 30 or less.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to prepare the uterus for a frozen embryo transfer: using the hormone letrozole or a standard artificial cycle. The goal is to see which approach works better for people with irregular periods.
This study compares two types of natural cycle preparation for frozen embryo transfers to see which leads to more pregnancies. It may be a good fit if you are using your own eggs, have regular cycles, and are planning a frozen embryo transfer.
This study measures changes in your blood immune markers during frozen embryo transfer when the embryo is chromosomally normal. It may help clinics understand what blood immune patterns relate to successful pregnancy in natural or hormone-prepared cycles.
This trial tests whether giving extra luteinizing hormone (LH) can improve embryo quality in women with very low LH levels during IVF. It may help you if you have low LH and are using a specific type of fertility medication.
This trial tests whether taking progesterone after a type of fertility treatment called IUI can improve success rates. The study focuses on people who are using a drug called letrozole to stimulate the ovaries.
This study looks at whether having a corpus luteum (the structure left after an egg is released) affects pregnancy outcomes in frozen embryo transfer cycles. It aims to help doctors choose the best way to prepare the body for embryo transfer.
Hear when a new Letrozole trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.